养老院2型糖尿病居民中滑动刻度胰岛素的使用:全国队列研究
结果显示第2周21%使用SSI,至第12周降至16%(线性趋势P<0.001),且糖尿病相关因素比衰弱相关因素与继续使用SSI或转换方案关联更强。
要点
- 养老院入院第2周21%的2型糖尿病居民使用SSI,为最常见的短效胰岛素方案。
- SSI使用率从第2周21%降至第12周16%(线性趋势P<0.001),主要通过停用SSI实现。
- 糖尿病相关因素(如高血糖)比衰弱相关因素与继续SSI或转换方案关联更强。
核心结论
- SSI是养老院居民中最常见的短效胰岛素给药方法。
- 需要更多研究探索为何SSI在入住养老院数周后仍持续使用,以及如何用更安全、有效且负担更小的方案替代。
研究设计与样本
- 比较入院第2周至第12周SSI与固定剂量胰岛素(FDI)或校正剂量胰岛素(CDI)的每周使用率。
- 在入院第2周使用SSI者中,分析第5周前停用SSI或转换为其他方案的相关因素。
主要发现
- 第2周队列中21%使用SSI,8%使用FDI,7%使用CDI。
- 在衰弱亚组中SSI是最常见方案,例如中度至重度认知障碍者中18%使用SSI,而FDI为5%、CDI为4%。
- SSI使用率从第2周21%稳步降至第12周16%(线性趋势P<0.001),主要因停用SSI。
- 糖尿病相关因素(如高血糖)比衰弱相关因素与继续使用SSI或转换为非SSI短效胰岛素方案关联更强。
临床怎么用
- 临床应关注养老院居民中SSI的持续使用,并考虑在入住1周后评估转换为更安全、有效且负担更小的方案。
局限性
- 原文未明确报告研究局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Guidelines discourage sliding scale insulin (SSI) use after the first week of a nursing home (NH) admission. We sought to determine the prevalence of SSI and identify factors associated with stopping SSI or transitioning to another short-acting insulin regimen. METHODS: In an observational study from October 1, 2013, to June 30, 2017 of non-hospice Veterans Affairs NH residents with type 2 diabetes and an NH admission over 1 week, we compared the weekly prevalence of SSI versus two other short-acting insulin regimens - fixed dose insulin (FDI) or correction dose insulin (CDI, defined as variable SSI given alongside fixed doses of insulin) - from week 2 to week 12 of admission. Among those on SSI in week 2, we examined factors associated with stopping SSI or transitioning to other regimens by week 5. Factors included demographics (e.g., age, sex, race/ethnicity), frailty-related factors (e.g., comorbidities, cognitive impairment, functional impairment), and diabetes-related factors (e.g., HbA1c, long-acting insulin use, hyperglycemia, and hypoglycemia). RESULTS: In week 2, 21% of our cohort was on SSI, 8% was on FDI, and 7% was on CDI. SSI was the most common regimen in frail subgroups (e.g., 18% of our cohort with moderate-severe cognitive impairment was on SSI vs 5% on FDI and 4% on CDI). SSI prevalence decreased steadily from 21% to 16% at week 12 (p for linear trend <0.001), mostly through stopping SSI. Diabetes-related factors (e.g., hyperglycemia) were more strongly associated with continuing SSI or transitioning to a non-SSI short-acting insulin regimen than frailty-related factors. CONCLUSIONS: SSI is the most common method of administering short-acting insulin in NH residents. More research needs to be done to explore why sliding scale use persists weeks after NH admission and explore how we can replace this practice with safer, more effective, and less burdensome regimens.
引用
- Lam K, Gan S, Nguyen B, et al. Sliding scale insulin use in a national cohort study of nursing home residents with type 2 diabetes. J Am Geriatr Soc. 2022. PMID: 35357692. doi:10.1111/jgs.17771
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。